ArticleBlood cancer journal2022

Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients.

Rong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.